Blueprint Investment Partners »

Vertex Pharmaceuticals Incorporated shares owned by Blueprint Investment Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Blueprint Investment Partners from 13F filings

Historical chart of Blueprint Investment Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Blueprint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Blueprint Investment Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $220k 633 347.74
2023-06-30 $301k 854 351.91
2022-09-30 $263k 910 289.01
2022-06-30 $293k 1.0k 281.46
2022-03-31 $251k 960 261.46
2021-12-31 $148k 674 219.60

More positions owned by Blueprint Investment Partners

SPDR Bloomberg 1-3 Month T-Bill Stock (BIL)
Tidal Tr Ii Blueprint Chesapea Ke Multi Stock (TFPN)
ClearShares Ultra-Short Maturity Stock (OPER)
SPDR Portfolio S&P 1500 Composite Stock ETF Stock (SPTM)
SPDR Portfolio Developed Wld ex-US Stock (SPDW)
iShares Short Treasury Bond Stock (SHV)
First Trust Small Cap Value AlphaDEX Stock (FYT)
NVIDIA Corp Stock (NVDA)
iShares Core S&P 500 Stock (IVV)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
SPDR Emerging Markets ETF Stock (SPEM)
iShares 0-3 Month Treasury Bond ETF Stock (SGOV)
Vanguard Developed Markets Index Fund ETF Stock (VEA)
Schwab US Broad Market ETF Stock (SCHB)

View all positions for Blueprint Investment Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated